Actively Recruiting

Age: 18Years - 89Years
All Genders
ID07175532

Prospective Multicenter Registry of Patients With Mitral Stenosis Undergoing Percutaneous Mitral Balloon Commissurotomy

Led by Asan Medical Center · Updated on 2025-09-16

400

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are conducting an observational study to learn about the clinical outcomes after percutaneous mitral balloon commissurotomy (PMBC) for patients with mitral stenosis (MS). The study uses a nationwide multicenter prospective registry that includes tertiary-referral hospitals in Korea. It aims to answer questions about the clinical outcomes after PMBC and which method is best to determine the inflated Inoue balloon size. This study observes patients with mitral stenosis who are undergoing PMBC without assigning treatments or interventions. It collects information from multiple hospitals to gather comprehensive data on this procedure. Participants are followed to track treatment-related adverse events from enrollment up to one year after PMBC. Participants will be involved in regular monitoring for up to one year after the procedure to assess any treatment-related side effects. Researchers will review clinical data and adverse events during this time. The study focuses on collecting information about safety and outcomes related to PMBC. Total participation duration depends on enrollment and follow-up through one year after treatment.

CONDITIONS

Brief Title

Prospective Multicenter Registry of Patients With Mitral Stenosis Undergoing Percutaneous Mitral Balloon Commissurotomy

Who Can Participate

Age: 18Years - 89Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with mitral stenosis undergoing PMBC
Not Eligible

You will not qualify if you...

  • Patients who cannot understand this study due to mental illness
  • Serious comorbidity limiting life expectancy within 1 year
  • Limited activity (NYHA class III or IV) due to non-cardiac disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Day of the procedure

Participants undergo percutaneous mitral balloon commissurotomy as part of routine care and are observed.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 1 year after the procedure

Participants are monitored for treatment-related adverse events and health outcomes after the procedure.

Periodic follow-up visits up to 1 year

Trial Site Locations

Total: 1 location

1

Asan Medical Center

Seoul, South Korea

Actively Recruiting

Loading map...

Research Team

J

Jong-Min Song

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Abbott Cephea Mitral Valve Disease Registry to Collect Data ...

Mitral Regurgitation

Actively Recruiting

22 locations

Comparison of Exercise Capacity, Muscle Oxygenation and Aort...

Mitral Stenosis

Actively Recruiting

1 location

Cephea South America Feasibility Study for Mitral Valve Dise...

Mitral Regurgitation

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here